Buy Rating Affirmed for Exact Sciences on Promising Multi-Cancer Detection Technology
TipRanksApr 10 02:17 ET
Exact Sciences Analyst Ratings
BenzingaApr 3 12:08 ET
Citigroup Maintains Buy on Exact Sciences, Announces $100 Price Target
BenzingaApr 3 12:10 ET
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and Geron (GERN)
TipRanksMar 19 02:40 ET
Buy Rating Affirmed for Exact Sciences Amid Market Expansion and Product Advancement Prospects
TipRanksMar 15 07:16 ET
Analysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Arcellx Inc (ACLX) and Exact Sciences (EXAS)
TipRanksMar 15 01:42 ET
Exact Sciences (EXAS) Receives a Buy From BTIG
TipRanksFeb 27 05:25 ET
Analysts Offer Insights on Healthcare Companies: Align Tech (ALGN), Exact Sciences (EXAS) and Springworks Therapeutics (SWTX)
TipRanksFeb 26 08:00 ET
Analysts' Opinions Are Mixed on These Healthcare Stocks: Exact Sciences (EXAS), United Therapeutics (UTHR) and Ionis Pharmaceuticals (IONS)
TipRanksFeb 25 23:50 ET
Exact Sciences Analyst Ratings
BenzingaFeb 22 14:38 ET
Piper Sandler Sticks to Their Buy Rating for Exact Sciences (EXAS)
TipRanksFeb 22 08:05 ET
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Denali Therapeutics (DNLI) and Treace Medical Concepts (TMCI)
TipRanksFeb 22 07:04 ET
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS) and Tandem Diabetes Care (TNDM)
TipRanksFeb 21 23:50 ET
Craig-Hallum Reaffirms Their Buy Rating on Exact Sciences (EXAS)
TipRanksFeb 20 08:39 ET
Analysts Offer Insights on Healthcare Companies: Exact Sciences (EXAS), Alnylam Pharma (ALNY) and Catalent (CTLT)
TipRanksFeb 20 07:31 ET
Craig-Hallum Reaffirms Their Buy Rating on Exact Sciences (EXAS)
TipRanksJan 8 08:56 ET
Analysts Are Bullish on These Healthcare Stocks: Intellia Therapeutics (NTLA), Exact Sciences (EXAS)
TipRanksJan 8 07:20 ET
Buy Rating for Exact Sciences: Strong Q4 Sales and Positive 2024 Outlook Drive Analyst Confidence
TipRanksJan 8 05:06 ET
Exact Sciences (EXAS) Receives a Buy From BTIG
TipRanksJan 7 05:32 ET
Benchmark Upgrades Exact Sciences to Buy, Announces $91 Price Target
BenzingaJan 2 06:59 ET
No Data
No Data